Overview of French databases available for studying anticancer drugs in real‐life setting
Author:
Affiliation:
1. Univ. Bordeaux, INSERM, BPH, U1219 Bordeaux F‐33000 France
2. MSD France Puteaux F‐92800 France
3. Service de Pharmacologie médicale Pôle de Santé Publique CHU de Bordeaux Bordeaux F‐33000 France
Publisher
Wiley
Subject
Pharmacology (medical),Pharmacology
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1111/fcp.12592
Reference55 articles.
1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2. Haute Autorité de Santé.UNITE METHODOLOGIE ET ETUDES POST‐INSCRIPTION Les études post‐inscription sur les technologies de santé (médicaments dispositifs médicaux et actes) Principes et méthodes. 2011 nov.
3. Availability of evidence of benefits on overall survival and quality of life of cancer drugs approved by European Medicines Agency: retrospective cohort study of drug approvals 2009–13;Davis C.;BMJ,2017
4. Enjeux et écueils des thérapies ciblées orales en pratique clinique quotidienne : 5e journée de pharmacologie des anti-tumoraux
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Development of Indirect Health Data Linkage on Health Product Use and Care Trajectories in France: Systematic Review;Journal of Medical Internet Research;2023-05-18
2. Drug–drug interactions of protein kinase inhibitors in chronic myeloid leukaemia patients: A study using the French health insurance database;Fundamental & Clinical Pharmacology;2023-04-24
3. Opportunities and Obstacles to the Development of Health Data Warehouses in Hospitals in France: The Recent Experience of Comprehensive Cancer Centers;International Journal of Environmental Research and Public Health;2023-01-16
4. Development of Indirect Health Data Linkage on Health Product Use and Care Trajectories in France: Systematic Review (Preprint);2022-07-18
5. The French Early Breast Cancer Cohort (FRESH): A Resource for Breast Cancer Research and Evaluations of Oncology Practices Based on the French National Healthcare System Database (SNDS);Cancers;2022-05-27
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3